Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression

<p>Figure S.1</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Xufeng Lu (14960724) (author)
Eará dahkkit:	Dazhuan E. Xin (14960727) (author), Juanjuan K. Du (14960730) (author), Quanli C. Zou (14960733) (author), Qian Wu (14960736) (author), Yanan S. Zhang (14960739) (author), Wenhai Deng (14960742) (author), Jicheng Yue (14960745) (author), Xing S. Fan (14960748) (author), Yuanyuan Zeng (9330065) (author), Xiaju Cheng (14960751) (author), Xue Li (14960754) (author), Zhaoyuan Hou (14960757) (author), Man Mohan (14960760) (author), Ting C. Zhao (14960763) (author), Xiaomei Lu (14960766) (author), Zhijie Chang (14960769) (author), Liyan Xu (14960772) (author), Yu Sun (14960775) (author), Xiongbing Zu (14960778) (author), Yu Zhang (14960781) (author), Y. Eugene Chinn (14960784) (author)
Almmustuhtton:	2025
Fáttát:	Cancer Cancer Biology Immuno-oncology Gynecological Cancers Uterine cancer Immunotherapy Combination immunotherapy Oncogenes & Tumor Suppressors Tumor suppressor genes
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid